Re: A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia

Steven A. Kaplan

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)213-214
Number of pages2
JournalJournal of Urology
Volume187
Issue number1
DOIs
StatePublished - Jan 2012

Cite this